However, there was no difference in the mRNA and protein expression of cyclin D1, TERT and p16 (INK4a) between COPD+EPCs and COPD+P5091 groups, indicating that the therapeutic effects of the two interventions were comparable. Here, CDKN2A is linked to chronic obstructive pulmonary disease.